What are the risks of COVID-19 infection in pregnant women?
Since December, 2019, the outbreak of the 2019 novel coronavirus disease (COVID-19) infection has become a major epidemic threat in China. Soe Zeya Tun/Reuters Previous studies have shown that SARS during pregnancy is associated with a high incidence of adverse maternal and neonatal complications, s...
Gespeichert in:
Veröffentlicht in: | The Lancet (British edition) 2020-03, Vol.395 (10226), p.760-762 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Since December, 2019, the outbreak of the 2019 novel coronavirus disease (COVID-19) infection has become a major epidemic threat in China. Soe Zeya Tun/Reuters Previous studies have shown that SARS during pregnancy is associated with a high incidence of adverse maternal and neonatal complications, such as spontaneous miscarriage, preterm delivery, intrauterine growth restriction, application of endotracheal intubation, admission to the intensive care unit, renal failure, and disseminated intravascular coagulopathy.9,11 However, pregnant women with COVID-19 infection in the present study had fewer adverse maternal and neonatal complications and outcomes than would be anticipated for those with SARS-CoV-1 infection. [...]pregnant women and newborn babies should be considered key at-risk populations in strategies focusing on prevention and management of COVID-19 infection. |
---|---|
ISSN: | 0140-6736 1474-547X |
DOI: | 10.1016/S0140-6736(20)30365-2 |